Double-blind, placebo-controlled, pilot trial of botulinum toxin A in restless legs syndrome

Neurology. 2008 Sep 16;71(12):950-1. doi: 10.1212/01.wnl.0000325994.93782.a1.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Intramural

MeSH terms

  • Botulinum Toxins, Type A / administration & dosage
  • Botulinum Toxins, Type A / adverse effects
  • Botulinum Toxins, Type A / therapeutic use*
  • Cross-Over Studies
  • Double-Blind Method
  • Female
  • Humans
  • Injections
  • Leg
  • Male
  • Middle Aged
  • Muscle Weakness / chemically induced
  • Neuromuscular Agents / administration & dosage
  • Neuromuscular Agents / adverse effects
  • Neuromuscular Agents / therapeutic use*
  • Pilot Projects
  • Restless Legs Syndrome / drug therapy*
  • Treatment Failure

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A